Searched for
ZYDUS JABS
Drug Controller General of India okays Corbevax for use in 12-18 age group"BE received the approval for restricted use in an emergency situation in adolescents aged 12 to less than 18 years based on interim result...- NTAGI may meet on Friday to review Covovax, CorbevaxBoth SII and Biological E are conducting Phase III trials of their vaccines on children. These could become the next choices of vaccines fo...
- Children aged 12-14 may get more vaccination optionsPeople in the government are hopeful that by the time vaccination starts for this age group, results of clinical trials of Covovax and Corb...
- Government nod to commercial export of Covishield, Covaxin in view of sufficient stockThe government, earlier in October, had permitted the SII to export 10 lakh Covishield doses each to Nepal, Myanmar and Bangladesh under th...
- Centre places purchase order for one crore doses of Zydus Cadila's needle-free Covid vaccineZydus Cadila is in a position to provide one crore doses of ZyCoV-D per month, company officials are learnt to have conveyed to the ministr...
- Vaccinations for healthy kids likely to start early next yearGovernment data shows that for children, hospitalisation in case of Covid 19 was extremely uncommon. It was also seen that children were mo...
- Govt expert panel recommends emergency use authorisation for Covaxin in 2 to 18 age group“Here the safety follow-up is longer. So, what we have done is that we have presented interim data. The trial design is such that one month...
- SEC set to review Covaxin trial data for use in childrenBharat Biotech has completed the Phase 2/3 trials of COVID-19 vaccine Covaxin for use in children under 18 years of age.
- Zydus Cadila proposes Rs 1900 for three-dose COVID vaccine; Govt negotiating to bring it downThe government had on Thursday said that the indigenously-developed, world's first DNA-based needle-free COVID-19 vaccine by Zydus Cadila w...
- India to procure 27-28 crore COVID-19 vaccine doses in October: SourcesMeanwhile, the government said Zydus Cadila's indigenously-developed needle-free COVID-19 vaccine ZyCoV-D will be introduced in the nationw...
- Centre working on pricing of Zydus Cadila COVID-19 vaccine, launch likely on October 2Its pricing will be decided at a meeting between company representatives and the National Expert Group in Vaccine Administration for Covid ...
- Covid jabs for children from next month? Top doctors in India to assess global dataThe country’s top paediatricians will review international data on children vaccinated against Covid-19 and present it to the National Tech...
- Zydus jab likely to cost more than Covishield, pricing to be out soonZydus Cadila's Covid vaccine, which is likely to be launched next month, may cost more than Covishield but will be comparable with those al...
- Drug regulator okays Zydus Cadila's three-dose Covid vaccine, first in India to be given to kids above 12The Indian drug regulator has given emergency use authorisation (EUA) to Zydus Cadila's three-dose Covid-19 vaccine, the ministry of scienc...
- India needs new vaccine launches to meet targetsThe government had in a presentation in May estimated that 216 crore vaccines will be available in the country between August and December.
- They volunteered to get jabbed before everyone else, now they don't have valid vaccine certificatesThey have urged the government either to help them get a vaccine certificate through the CoWIN platform or issue an official order stating ...
- Zydus Cadila's vaccine for kids above 12 to come up for approval this weekThe drug regulator will consider emergency use approval for Covid vaccines developed by Zydus Cadila for children above 12 this week. The r...
- Zydus Cadila likely to seek emergency use authorisation for its Covid vaccine next weekPharmaceutical major Zydus Cadila has told the Centre that it could apply for emergency use authorisation (EUA) for ZyCoV-D vaccine in the ...
- Global vaccine makers respond to UP's call for 4 crore jabsAt a pre-bid meeting on Wednesday, Dr Reddy’s, Zydus Cadila, Pfizer, Bharat Biotech, Serum Institute and a Korean firm held talks with stat...
- Stocks of pharma companies linked to vaccines rallyThe Centre recently announced the expansion of the vaccination drive to cover those aged 18-45 years. It also allowed vaccines for the priv...
Load More
